Advanced search
Publication Cover
Clinical Pharmacology: Advances and Applications Volume 3, 2011 - Issue
Submit an article Journal homepage
220
Views
12
CrossRef citations to date
0
Altmetric
Case Series

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

Mahmud Mahamid1 Liver Unit, Holy Family Hospital, Nazareth, Israel;3 Shaare Zedek Medical Center, Jerusalem, IsraelCorrespondence[email protected]
,
Reuven Mader4 Rheumatology Unit, Ha’emek Medical Center, Afula, Israel
&
Rifaat Safadi1 Liver Unit, Holy Family Hospital, Nazareth, Israel;2 Hadassah Medical Center, Jerusalem, Israel
Pages 39-43 | Published online: 04 Oct 2011

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Harpal Singh Sandhu & Henry J Kaplan. (2018) Novel therapies in the treatment of noninfectious uveitis. Expert Review of Ophthalmology 13:3, pages 139-147.
Read now
Cristina Ulivieri & Cosima T Baldari. (2013) T-cell-based immunotherapy of autoimmune diseases. Expert Review of Vaccines 12:3, pages 297-310.
Read now

Articles from other publishers (10)

Tarana Gupta & Hemant Sharma. (2023) COVID-19 and the liver: Are footprints still there?. World Journal of Gastroenterology 29:4, pages 656-669.
Crossref
V. I. Petrov, A. Y. Ryazanova, D. A. Nekrasov, V. I. Svinukhov & N. S. Privaltseva. (2022) Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors. Safety and Risk of Pharmacotherapy 10:1, pages 34-47.
Crossref
Bethany H. James, Pantelitsa Papakyriacou, Matthew J. Gardener, Louise Gliddon, Christopher J. Weston & Patricia F. Lalor. (2022) The Contribution of Liver Sinusoidal Endothelial Cells to Clearance of Therapeutic Antibody. Frontiers in Physiology 12.
Crossref
Tiziano Balzano, Omar El Hiba, Natalia López-González del Rey, Souad El Amine & Kamal Smimih. 2022. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19 141 158 .
Antonio Vitiello, Raffaele La Porta, Vilma D’Aiuto & Francesco Ferrara. (2021) The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egyptian Liver Journal 11:1.
Crossref
Ana Delgado, Stefan Stewart, Mikel Urroz, Amelia Rodríguez, Alberto M. Borobia, Ibtissam Akatbach-Bousaid, Miguel González-Muñoz & Elena Ramírez. (2021) Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. Journal of Clinical Medicine 10:19, pages 4432.
Crossref
Xinyi Wang, Jianyong Lei, Zhihui Li & Lunan Yan. (2021) Potential Effects of Coronaviruses on the Liver: An Update. Frontiers in Medicine 8.
Crossref
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar & Raj Kumar Singh. (2020) Drug repurposing approach to fight COVID-19. Pharmacological Reports 72:6, pages 1479-1508.
Crossref
Sophie L. Penman, Robyn T. Kiy, Rebecca L. Jensen, Christopher Beoku‐Betts, Ana Alfirevic, David Back, Saye H. Khoo, Andrew Owen, Munir Pirmohamed, B. Kevin Park, Xiaoli Meng, Christopher E. Goldring & Amy E. Chadwick. (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology 177:19, pages 4353-4374.
Crossref
. (2013) Anakinra/tocilizumab. Reactions Weekly 1387:1, pages 8-8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.